MorgansACF has acquired two businesses in the Industrial Access space for a total consideration of $29m (including earn-out payments). This implies an EV/EBITDA multiple of ~4x (before synergies), which is consistent with management's target for acquisitions.Management has decreased FY25 earnings guidance due to ongoing project delays. We see this as largely a timing issue with EBITDA of ~$9m pushed into FY26.Factoring in the acquisitions and updated earnings guidance sees FY25/26/27F EBITDA change by -4%/+3%/+2%.Our target price remains unchanged at $1.32 and we maintain our Add rating. While project delays are impacting earnings in FY25, year-to-date (YTD) secured hire contract wins (a key leading indicator of future performance) jumped 35%. This suggests to us that the pipeline remains strong and will underpin solid growth for ACF when activity picks up (particularly in QLD as infrastructure projects associated with the Brisbane Olympics need to start soon to be ready for the event in 2032).
- Forums
- ASX - By Stock
- Ann: ACF Completes Two Industrial Access Deals, Updates Guidance
ACF
acrow limited
Add to My Watchlist
0.51%
!
98.5¢

MorgansACF has acquired two businesses in the Industrial Access...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
98.5¢ |
Change
-0.005(0.51%) |
Mkt cap ! $303.3M |
Open | High | Low | Value | Volume |
98.0¢ | 99.0¢ | 97.5¢ | $221.7K | 225.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 3024 | 98.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
99.0¢ | 107627 | 6 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 3024 | 0.985 |
1 | 15826 | 0.980 |
4 | 19033 | 0.975 |
5 | 40869 | 0.970 |
4 | 33036 | 0.965 |
Price($) | Vol. | No. |
---|---|---|
0.990 | 107627 | 6 |
0.995 | 10000 | 1 |
1.000 | 16900 | 1 |
1.010 | 10927 | 2 |
1.020 | 4000 | 1 |
Last trade - 16.10pm 01/07/2025 (20 minute delay) ? |
Featured News
ACF (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Dr. Steven Gourlay, CEO
Dr. Steven Gourlay
CEO
Previous Video
Next Video
SPONSORED BY The Market Online